PALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws & Paws Conference. Management will be presenting on Wednesday, May 28, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at investor.zimvie.com. About ZimVieZimVie is a global lif ...

Net Sales from Continuing Operations of $112.0 millionNet Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA[1] from Continuing Operations of $17.6 million; Adjusted EBITDA[1] margin of 15.7%GAAP diluted EPS from Continuing Operations of $(0.09) and adjusted diluted EPS[1] from Continuing Operations of $0.27 PALM BEACH GARDENS, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financ ...

公司业绩表现 - 2025年第一季度销售额同比增长69%至1332亿美元，非GAAP核心销售额增长78% [9][15] - 营业利润率为242%，非GAAP调整后营业利润率提升至250% [9][17] - 净利润达225亿美元，稀释后每股收益为090美元，非GAAP调整后每股收益为095美元 [9][15][17] - 经营现金流157亿美元，非GAAP自由现金流142亿美元，同比增长约390% [9][25] 业务部门表现 - 产品质量与创新(PQI)部门核心销售额增长83%，受益于消费品包装市场的积极趋势 [4][21] - 水质部门在北美地区水处理解决方案增长强劲，欧洲地区水分析业务实现两位数增长 [4][21] - 公司整体核心销售额增长78%，水质部门增长74%，PQI部门增长83% [21] 2025年财务指引 - 第二季度非GAAP核心销售额预计同比增长低至中个位数，调整后稀释每股收益084-088美元 [7][23] - 全年调整后每股收益指引维持360-370美元，自由现金流转换率预计90%-100% [8][23] - 预计全年核心销售额增长低至中个位数，调整后营业利润率同比持平至上升50个基点 [8][23] 战略与市场定位 - 公司通过商业团队执行战略举措获得新客户并提高市场渗透率 [3] - 针对全球经济变化实施多项应对措施以减轻关税影响并增强运营灵活性 [5] - 公司业务模式稳健，终端市场长期增长动力强劲，为所有利益相关者创造短期和长期价值 [5]